- Revoss Mineralized Cortical/Cancellous Bone Allograft with 250-1000µm particle size, human tissue allograft is used primarily by oral surgeons and periodontists for dental bone regeneration and implant site preparation
Uses
- Large Lateral Window Sinus Lifts:
- Filling extensive maxillary sinus cavities to support multiple posterior dental implants
- Full-Arch or Quadrant Socket Preservation:
- Filling several adjacent extraction sites simultaneously during full-mouth clearings and restorations
- Major Block & Ridge Augmentations:
- Rebuilding severe horizontal or vertical ridge bone loss over a long span of teeth
- Cystic & Pathology Cavity Filling:
- Rebuilding extensive skeletal voids remaining after the removal of large dental cysts, granulomas, or benign oral tumors
- Maxillofacial Reconstruction:
- Repairing advanced bony defects or contours originating from localized jaw trauma
Features
- 50/50 Mineralized Blend:
- Combines equal parts cortical (dense, structural) and cancellous (spongy, porous) human bone powder
- 250-1000µm Particle Size:
- Optimized grain size for easy packing into small dental bone voids
- Extra-Large 2.5cc Volume:
- The highest available powder volume in the Revoss series, providing substantial grafting material for major procedures
- Strict Regulatory Standards:
- Sourced and processed in the USA following strict American Association of Tissue Banks (AATB) standards and FDA regulations (21 CFR Part 1271)
- Extended Shelf Life:
- Offers a long-term stable shelf life for convenient inventory storage
Benefits
- Dual-Action Bone Regeneration:
- The cancellous bone component provides a highly porous framework that accelerates cellular attachment and neovascularization while concurrently, the cortical component offers density and structural stability while the body heals
- High Biocompatibility:
- Because it is a 100% human allograft, the patient's body readily recognizes, resorbs, and replaces the material with healthy, natural host bone over time
- Patient Safety:
- Rigorous donor screening and validated tissue-cleaning protocols virtually eliminate the risk of disease transmission
- Maximum Cost Efficiency:
- Minimizes clinical waste and operational overhead by preventing the need to unseal three or four smaller vials during extensive bone grafting surgeries
